3 Firms Win 25% Fee Approval For $3.5M Ariad Deal
A Massachusetts federal judge on Thursday afternoon gave his approval to a $3.5 million class action settlement between a group of investors and Takeda Pharmaceutical Co. unit Ariad Pharmaceuticals Inc., including...To view the full article, register now.
Already a subscriber? Click here to view full article